| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/11/2002 | WO2000058523A9 Glucocorticoid receptor agonist and decreased pp5 |
| 04/11/2002 | WO2000052210A3 Methods for targeting rna molecules |
| 04/11/2002 | WO2000052167A9 Angiopoietin-related protein and nucleic acids |
| 04/11/2002 | WO2000049164A9 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 04/11/2002 | WO2000042068A9 Hiv related peptides |
| 04/11/2002 | WO2000038518A9 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | WO2000032774A9 12216 receptor, a g-protein coupled receptor |
| 04/11/2002 | WO2000028008A9 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
| 04/11/2002 | WO2000026819A9 Methods and apparatus for performing pattern dictionary formation for use in sequence homology detection |
| 04/11/2002 | WO2000011188A9 Transgenic microbial polyhydroxyalkanoate producers |
| 04/11/2002 | US20020042934 Two phase nucleic acid constructs coding for proteins tolerant to plastid non-lethal/lethal compounds; genetic engineering |
| 04/11/2002 | US20020042933 Desaturating omega-6 fatty acid with recombinant polypeptide |
| 04/11/2002 | US20020042932 Recombinant vector containing prokaryotic gene from bacillus or intestinal bacteria including ubiquitin promoter that targets cytosol or plastid of host plant, enhancing photosynthetic efficiency |
| 04/11/2002 | US20020042931 Via overexpressed bicarbonate transporter; genetic engineering; plants |
| 04/11/2002 | US20020042930 Regulation and manipulation of sucrose content in sugarcane |
| 04/11/2002 | US20020042929 Isolating a maize embryo, culturing that embryo to produce callus cells, and bombarding the callus cells with particles coated with copies of a nucleic acid construct |
| 04/11/2002 | US20020042928 Methods for maximizing expression of transgenic traits in autopolyploid plants |
| 04/11/2002 | US20020042926 Ovary-specific genes and proteins |
| 04/11/2002 | US20020042679 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains |
| 04/11/2002 | US20020042506 Contacting with porous cation and anion exchange resins; does not bind or remove the DNA of interest |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042504 Nucleotide sequence similar to semaphorin proteins |
| 04/11/2002 | US20020042503 Diagnosis, drug screening, clinical trial monitoring, and disease treatment |
| 04/11/2002 | US20020042502 Preparation of capped mRNA |
| 04/11/2002 | US20020042389 IGF-1 receptor interacting proteins |
| 04/11/2002 | US20020042388 Gene therapy for liver, lungs, tissues; determination, calibration of solution turbidity |
| 04/11/2002 | US20020042387 Administering nucleic acid as antiinflammatory agent |
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042384 Integrin-targeting vectors having transfection activity |
| 04/11/2002 | US20020042383 Antiinflammatory agents |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042369 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042364 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 04/11/2002 | US20020042149 Analyzing preferential particles in bodily fluid; obtain sample, incubate with binding particles, detect bound particles |
| 04/11/2002 | US20020042139 Amplifying cell transformation efficiency; obtain cells, transform with replication defective vectors, monitor transformed cells for preferential gene expression |
| 04/11/2002 | US20020042138 Inducing globin gene expression in cells; obtain cells, incubate with preferential nucleotide sequences, monitor cells for amplified globin expression |
| 04/11/2002 | US20020042137 System for generating recombinant viruses |
| 04/11/2002 | US20020042136 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 04/11/2002 | US20020042135 Kit for in transform and expression of heterologous gene in bacterial |
| 04/11/2002 | US20020042134 Modification of bacteria |
| 04/11/2002 | US20020042133 Immortalised cell line derived from normal human skin tissues |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/11/2002 | US20020042129 Keratinocytes and melanocytes; without any feeder cells; maintain the ability to express keratins, cytochromes, as well as other differentiation proteins |
| 04/11/2002 | US20020042123 yybQ |
| 04/11/2002 | US20020042122 Mammalian proteins; related reagents and methods |
| 04/11/2002 | US20020042119 Novel Metalloproteinases |
| 04/11/2002 | US20020042118 Isolated nucleic acid fragment encoding said proteins and chimeric microorganisms tranformed with said fragments capable of expressing phenol-induced proteins |
| 04/11/2002 | US20020042117 Genes encoding picric acid degradation |
| 04/11/2002 | US20020042115 Regulation of human S-acyl fatty acid synthase thioesterase-like enzyme |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042113 Nucleotide sequences or use in the generation of disease resistant plants |
| 04/11/2002 | US20020042110 Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme |
| 04/11/2002 | US20020042104 Generation of preferential compounds in culture; obtain genetically engineered microorganism, culture, recover preferential compounds |
| 04/11/2002 | US20020042102 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042100 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 04/11/2002 | US20020042099 2504, 15977, and 14760, novel protein kinase family members and uses therefor |
| 04/11/2002 | US20020042098 32253 transferase family members and uses therefor |
| 04/11/2002 | US20020042097 Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
| 04/11/2002 | US20020042089 Interleukin-5 specific recombinant antibodies |
| 04/11/2002 | US20020042087 Inducing preferential cell proliferation; obtain preferential cells, incubate with modulator, monitor cell sample for proliferation activity |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020042071 Sequencing nucleic acid using labeled nucleotide phosphate probes |
| 04/11/2002 | US20020042070 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips |
| 04/11/2002 | US20020042068 Glass capillary for DNA analysis and manufacturing method thereof, and DNA analyzer that uses the glass capillary |
| 04/11/2002 | US20020042064 p53 binding areas |
| 04/11/2002 | US20020042058 18057 protein, a novel seven transmembrane protein |
| 04/11/2002 | US20020042057 Nucleotide sequences for use in the treatment of cardiomyopathies |
| 04/11/2002 | US20020042052 Method of removing nucleic acid contamination in amplification reactions |
| 04/11/2002 | US20020042051 Automated analysis of real-time nucleic acid amplification |
| 04/11/2002 | US20020042048 Detection of preferential nucleotide sequences; obtain sequences, incubate with probes, monitor hybridization for inaccurate fitting |
| 04/11/2002 | US20020042047 Factorial chemical libraries |
| 04/11/2002 | US20020042045 METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL HTLV-II nra ENVELOPE PEPTIDES |
| 04/11/2002 | US20020042044 Cells of Dictyostelium discoideum are contacted with candidate agents and the expression of genes in the Nucleotide Excision Repair and Base Excision Repair pathways are examined |
| 04/11/2002 | US20020041882 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041875 Inhibition of complement C5 activation for treatment and prevention of delayed xenograft/acute vascular rejection |
| 04/11/2002 | US20020041870 Novel genes expressed in obese rat hypothalamus |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | US20020041867 Microencapsulated dna for vaccination and gene therapy |
| 04/11/2002 | US20020040873 Separation Dna sequences; gel filtration |
| 04/11/2002 | US20020040872 Device and methods for subdividing and filtering gel material and extracting molecules therefrom |
| 04/11/2002 | DE10132724A1 Für das dctA-Gen kodierende Nukleotidsequenzen For the dctA gene encoding nucleotide sequences |
| 04/11/2002 | DE10130192A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the fermentative preparation of L-amino acids using strains of the family Enterobacteriaceae |
| 04/11/2002 | DE10123070A1 Neue für das atr43-Gen kodierende Nukleotidsequenzen New coding for the atr43 gene nucleotide sequences |
| 04/11/2002 | DE10109685A1 Neue für das sahH-Gen kodierende Nukleotidsequenzen New coding for the sahH gene nucleotide sequences |
| 04/11/2002 | DE10100586C1 Inhibiting gene expression in cells, useful for e.g. treating tumors, by introducing double-stranded complementary oligoRNA having unpaired terminal bases |
| 04/11/2002 | DE10052319A1 New nucleic acid encoding mutant factor 7 activating protease, useful for diagnosis, treatment and prevention of coagulation disorders, also related protein and antibodies |
| 04/11/2002 | DE10048950A1 Activating p53-responsive promoter, useful for treating tumors that contain mutant forms of p53, using an adaptor protein that links the promoter to mutated p53 |
| 04/11/2002 | DE10048417A1 Verbindungen mit verzweigtem Linker Compounds with branched linker |
| 04/11/2002 | DE10048214A1 Pflanzen mit maskierter Fruchtbarkeit Plants with masked fertility |
| 04/11/2002 | DE10047866A1 Neue für das dep67-Gen kodierende Nukleotidsequenzen New coding for the dep67 gene nucleotide sequences |
| 04/11/2002 | DE10047404A1 Neue für das msik-Gen kodierende Nukleotidsequenzen New coding for the msiK gene nucleotide sequences |
| 04/11/2002 | DE10047403A1 Neue für das ppgK-Gen kodierende Nukleotidsequenzen New coding for the pPGK gene nucleotide sequences |
| 04/11/2002 | DE10047142A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure unter Verwendung coryneformer Bakterien A process for the fermentative preparation of D-pantothenic acid using coryneform bacteria |